Sripath Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 3.63 Cr
as on 20-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.96 M
as on 20-12-2024
- Revenue 84.65%
(FY 2022)
- Profit 518.10%
(FY 2022)
- Ebitda 312.17%
(FY 2022)
- Net Worth 139.25%
(FY 2022)
- Total Assets 57.83%
(FY 2022)
About Sripath Diagnostics
The Corporate was formerly known as Simhapuri Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.63 Cr.
The company currently has active open charges totaling ₹2.96 M.
Adluri Prasad and Ranjani Chakravarthy serve as directors at the Company.
- CIN/LLPIN
U93030TG2014PTC092566
- Company No.
092566
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sripath Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adluri Prasad  | Director | 29-Jan-2014 | Current |
| Ranjani Chakravarthy | Director | 30-Jul-2015 | Current |
Financial Performance of Sripath Diagnostics.
Sripath Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 84.65% increase. The company also saw a substantial improvement in profitability, with a 518.1% increase in profit. The company's net worth Soared by an impressive increase of 139.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sripath Diagnostics?
In 2021, Sripath Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sripath Medical Systems Private LimitedActive 3 years 3 monthsAdluri Prasad and Ranjani Chakravarthy are mutual person
- Sripath Diagnostics Nizamabad Private LimitedActive 2 years 3 months
Ranjani Chakravarthy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Oct 2022 | ₹2.46 M | Open |
Hdfc Bank Limited Creation Date: 02 Dec 2021 | ₹0.51 M | Open |
How Many Employees Work at Sripath Diagnostics?
Sripath Diagnostics has a workforce of 73 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sripath Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sripath Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
